GILD vs RGLD · P/E 18, rev $7.80B vs P/E 26, rev $919.7M
Gilead Sciences Inc (GILD) versus Royal Gold Inc (RGLD) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US. It is led by Daniel P. O'Day.
Royal Gold Inc (RGLD) is a gold company listed on NASDAQ.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported RGLD revenue for 2026-06-30 was $919.7M. Net income was $517.5M. Revenue was up 96.0% from 2026-03-31 to 2026-06-30. RGLD currently screens at market cap $18.54B and trailing P/E 26.4.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. RGLD currently screens at market cap $18.54B and trailing P/E 26.4.
Not investment advice. Open the GILD and RGLD stock pages for the full models.
Not investment advice.